UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------------
OMB APPROVAL
----------------------------
OMB Number: 3235-0145
----------------------------
Expires: December 31, 2005
----------------------------
Estimated average burden
---------------------------
hours per response. . . 11
----------------------------
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
DUSA Pharmaceuticals, Inc.
-------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, no par value
-------------------------------------------------------------------------------
(Title of Class of Securities)
266898105
--------------------------------------------
(CUSIP Number)
April 8, 2004
-------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
--------------------------------------------------------------------------------
CUSIP No. 266898105 SCHEDULE 13G Page 2 of 5 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS./I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(Entities Only).
North Sound Capital LLC (1)
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(See Instructions)
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
5. SOLE VOTING POWER 0
NUMBER OF
SHARES ----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER 836,317
OWNED BY
EACH ----------------------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER 0
PERSON
WITH ----------------------------------------------------------------
8. SHARED DISPOSITIVE POWER 836,317
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
836,317
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
(See Instructions)
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.1%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
(1) The ultimate managing member of North Sound Capital LLC is Thomas McAuley.
The Reporting Person may be deemed the beneficial owner of the shares in
its capacity as the managing member of North Sound Legacy Fund LLC, North
Sound Legacy Institutional Fund LLC and North Sound Legacy International
Ltd. (the "Funds"), who are the holders of such shares. As the managing
member of the Funds, the Reporting Person has voting and investment control
with respect to the shares of common stock held by the Funds.
--------------------------------------------------------------------------------
CUSIP No. 266898105 SCHEDULE 13G Page 3 of 5 Pages
--------------------------------------------------------------------------------
Item 1(a). Name of Issuer:
DUSA Pharmaceuticals, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
25 Upton Drive
Wilmington, Massachusetts 01887
Item 2(a). Name of Person Filing.
Item 2(b). Address of Principal Business Office or, if None, Residence.
Item 2(c). Citizenship.
North Sound Capital LLC
53 Forest Avenue, Suite 202
Old Greenwich, CT 06870
Delaware limited liability company
Item 2(d). Title of Class of Securities:
Common Stock, no par value
Item 2(e). CUSIP Number:
266898105
Item 3. If this statement is filed pursuant to ss.ss.240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:
Not Applicable
Item 4. Ownership.
The following is information regarding the aggregate number
and percentage of the class of securities of the issuer
identified in Item 1 as of April 8, 2004:
(a) Amount beneficially owned: 836,317 shares of Common Stock
(b) Percent of Class: 5.1%
(c) Number of shares as to which such person has:
(i) sole power to vote or direct the vote: 0
(ii) shared power to vote or direct the vote: 836,317
--------------------------------------------------------------------------------
CUSIP No. 266898105 SCHEDULE 13G Page 4 of 5 Pages
--------------------------------------------------------------------------------
(iii) sole power to dispose or direct the disposition
of: 0
(iv) shared power to dispose or direct the
disposition of: 836,317
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
Not Applicable
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company.
Not Applicable
Item 8. Identification and Classification of Members of the Group.
Not Applicable
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
Certification pursuant to ss.240.13d-1(c):
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.
--------------------------------------------------------------------------------
CUSIP No. 266898105 SCHEDULE 13G Page 5 of 5 Pages
--------------------------------------------------------------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: April 15, 2004
NORTH SOUND CAPITAL LLC
By: /s/ Thomas McAuley
---------------------------------
Name: Thomas McAuley
Title: Chief Investment Officer